# Safety of Autologous MSC Infusion to Treat Epilepsy

> **NCT02497443** · PHASE1,PHASE2 · COMPLETED · sponsor: **Ministry of Public Health, Republic of Belarus** · enrollment: 60 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **BIOLOGICAL:** Autologous mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02497443
- **Lead sponsor:** Ministry of Public Health, Republic of Belarus
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2017-12
- **Final completion:** 2019-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2022-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02497443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02497443, "Safety of Autologous MSC Infusion to Treat Epilepsy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02497443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*